These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 467465)

  • 21. Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone.
    Fehske KJ; Schläfer U; Wollert U; Müller WE
    Mol Pharmacol; 1982 Mar; 21(2):387-93. PubMed ID: 6808349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies of phenytoin binding to human serum albumin by high-performance affinity chromatography.
    Chen J; Ohnmacht C; Hage DS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Sep; 809(1):137-45. PubMed ID: 15282104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The binding of L-tryptophan to serum albumins in the presence of non-esterified fatty acids.
    Cunningham VJ; Hay L; Stoner HB
    Biochem J; 1975 Mar; 146(3):653-8. PubMed ID: 1147909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of palmitate and oleate on the binding of warfarin to human serum albumin: stopped-flow studies.
    Rietbrock N; Menke G; Reuter G; Lassmann A; Schmeidl R
    J Clin Chem Clin Biochem; 1985 Nov; 23(11):719-23. PubMed ID: 4086977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of fatty acids on human serum albumin binding centers.
    Dobretsov GE; Syrejshchikova TI; Smolina NV; Uzbekov MG
    Bull Exp Biol Med; 2012 Jul; 153(3):323-6. PubMed ID: 22866302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of fatty acids on the interaction of 1-anilino-8-naphthalenesulfonate with human plasma albumin.
    Santos EC; Spector AA
    Mol Pharmacol; 1974 May; 10(3):519-28. PubMed ID: 4851749
    [No Abstract]   [Full Text] [Related]  

  • 27. Binding of urapidil to human serum albumin: dependency on free fatty acid concentration.
    Storck J; Kirsten R
    Int J Clin Pharmacol Ther Toxicol; 1991 May; 29(5):204-8. PubMed ID: 2071271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Azapropazone binding to human serum albumin.
    Fehske KJ; Jähnchen E; Müller WE; Stillbauer A
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Aug; 313(2):159-63. PubMed ID: 7422015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding of 3-carbethoxipsoralen to human serum albumin and human serum: influence of free fatty acids.
    Font G; Mañes J; Martre H; Prognon P; Mahuzier G
    Rev Esp Fisiol; 1987 Sep; 43(3):317-21. PubMed ID: 3423390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determinants of the plasma protein binding of theophylline in health.
    Buss D; Leopold D; Smith AP; Routledge PA
    Br J Clin Pharmacol; 1983 Apr; 15(4):399-405. PubMed ID: 6849774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenytoin binding to partially purified albumin in renal disease.
    Kinniburgh DW; Boyd ND
    Clin Pharmacol Ther; 1981 Feb; 29(2):203-10. PubMed ID: 7460484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thermodynamics of fatty acid anion displacement of warfarin and phenylbutazone from human albumin.
    Rippie EG
    Biochem Pharmacol; 1976 May; 25(10):1215-6. PubMed ID: 938544
    [No Abstract]   [Full Text] [Related]  

  • 33. Role of alpha-1 acid glycoprotein, albumin, and nonesterified fatty acids in serum binding of apazone and warfarin.
    Urien S; Albengres E; Pinquier JL; Tillement JP
    Clin Pharmacol Ther; 1986 Jun; 39(6):683-9. PubMed ID: 3709033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Valproic acid: in vitro plasma protein binding and interaction with phenytoin.
    Cramer JA; Mattson RH
    Ther Drug Monit; 1979; 1(1):105-16. PubMed ID: 121944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of the fluorescence probe 1-anilino-8-naphthalenesulfonate in predicting interindividual differences in the plasma protein binding of acidic drugs in rats.
    Sato J; Sugiyama Y; Hanano M
    J Pharm Sci; 1984 Apr; 73(4):519-24. PubMed ID: 6726638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Binding of phenytoin to serum albumin in vitro and in vivo].
    Pospísil J; Perlík F; Kordac V; Kolínová M
    Cesk Farm; 1991 Dec; 40(6-7):200-2. PubMed ID: 1823294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding study of the fluorescence probe 1-anilino-8-naphthalensulfonate to human plasma and human and bovine serum albumin using potentiometric titration.
    Valsami GN; Macheras PE; Koupparis MA
    Pharm Res; 1991 Jul; 8(7):888-92. PubMed ID: 1924140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding in vitro of pipequaline (45319 RP) onto plasma proteins and blood cells in man.
    Essassi D; Zini R; Hamberger C; Urien S; Rougeot C; Uzan A; Tillement JP
    Biochem Pharmacol; 1987 Oct; 36(20):3501-7. PubMed ID: 2890351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of phenylbutazone, tolbutamide, and clofibric acid on binding of racemic warfarin and its enantiomers to human serum albumin.
    Veronich K; White G; Kapoor A
    J Pharm Sci; 1979 Dec; 68(12):1515-8. PubMed ID: 529041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal function and therapeutic concentrations of phenytoin.
    Liponi DF; Winter ME; Tozer TN
    Neurology; 1984 Mar; 34(3):395-7. PubMed ID: 6538287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.